Medical consultation platform developer Ubie has received $18.4m from medicine distributor Suzuken that will be used to enhance its apps, increase headcount and expand internationally.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Novartis bought $10m in shares as the fibrosis treatment developer floated at the top of its range in an expanded initial public offering.

Circulating tumour DNA blood test developer Base Genomics has raised $11m to progress research out of University of Oxford.

NodThera, a developer of treatments for conditions caused by chronic inflammation, has completed a Novo Ventures-led round that also featured Sanofi Ventures.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Pfizer Breakthrough Growth Initiative is set to allocate as much as $500m to publicly listed clinical-stage life science technology developers.

MassMutual Ventures now has $450m under management across five funds, with its third main fund to invest in North America, Europe and Israel.

Bigfoot Medical, which is developing smart pens for diabetes management, closed an Abbott-led series C round after securing $45m in the first tranche in January.

Fosun and Varian Medical Systems returned to help medical imaging platform developer Arterys increase its total funding to $70m.